嵌合式抗原受体治疗中的先天性免疫细胞
Marius Jassaud1, Lydia Ziane-Chaouche1, Marie Duhamel1
1Université de Lille, INSERM, CHU Lille, U1192 - Protéomique Réponse Inflammatoire Spectrométrie de Masse (PRISM), Equipe Labellisée Ligue Contre le Cancer, 59000 Lille, France.
概括
化学抗原受体 (CAR) 疗法通过工程天生的免疫细胞显示出对固体瘤的希望. 这些CAR-天生的细胞比CAR-T细胞具有优势,有可能克服当前的治疗挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 化学抗原受体 (CAR) T细胞疗法已经改变了癌症治疗,特别是血液癌症.
- 显著的挑战阻碍了CAR-T细胞在固体瘤中的疗效,包括毒性和制造成本.
- 正在探索替代性免疫效应细胞来克服这些局限性.
研究的目的:
- 审查CAR工程天生的免疫细胞的生物基础和临床潜力.
- 为突出利用先天性免疫细胞用于固体瘤治疗的进展.
- 讨论下一代基于CAR的治疗方法的未来战略.
主要方法:
- 关于CAR工程天生的免疫细胞的临床前和临床研究的综述.
- 分析天生的免疫细胞 (NK细胞,巨细胞等) 的优势. 在T细胞上.
- 探索用于增强疗效的组合策略.
主要成果:
- 天生的免疫细胞提供了诸如较低的移植与宿主疾病风险和适合现成平台的优势.
- 经过CAR工程的先天细胞显示出改善瘤透和降低毒性的潜力.
- 临床前和早期临床数据支持这些基于CAR的新方法的可行性.
结论:
- 在固体瘤治疗中,CAR-工程天生的免疫细胞代表了CAR-T细胞的有希望的替代品.
- 在固体瘤中克服挑战可能可以通过基于先天性免疫细胞的CAR疗法来实现.
- 未来的研究应该专注于组合策略和优化CAR天生的细胞平台.
相关概念视频
Cell-mediated Immune Responses
83.5K
Overview
83.5K
Diversity of Antigen Receptors
1.4K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.4K
Cells of the Adaptive Immune Response
8.5K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.5K
T Cell Activation and Clonal Selection
14.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.7K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


